Trump’s Pick for Commerce Secretary Reveals Positions at More Than 800 Companies
Howard Lutnick, the wealthy Wall Street executive whom President Trump has tapped to lead the Department of Commerce, detailed a complex network of financial holdings on Friday as he prepared to face scrutiny from lawmakers during a confirmation hearing next week.
Howard Lutnick, Trump's Pick to Run Commerce Department, Releases Financial Disclosures
Howard Lutnick, President Donald Trump's nominee to lead the Commerce Department, on Friday disclosed his financial holdings and assets ahead of a Senate hearing to confirm him for the role. The Wall Street CEO earned nearly $200 million through financial services company Cantor Fitzgerald.
Lutnick is stepping down as head of investment bank Cantor Fitzgerald as he prepares to head the Commerce Department.
Cantor Fitzgerald restated their overweight rating on shares of Amazon.com (NASDAQ:AMZN) in a report issued on Wednesday ...
The 20-foot wide mansion was built in 1869 along with three others on East 74th Street, and was significantly redesigned in ...
2don MSN
Brett Knoblauch, Cantor Fitzgerald head of digital asset research, joins 'Power Lunch' to discuss the energy needed to power ...
Equities research analysts at Cantor Fitzgerald lowered their FY2024 EPS estimates for AxoGen in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst R. Osborn now forecasts that the ...
Tether has undeniably played a pivotal role in bridging traditional finance with the digital currency world. However, its ...
Cantor Fitzgerald analyst Colin Canfield raised the firm’s price target on Redwire (RDW) to $28 from $6 and keeps an Overweight rating on the ...
Cantor Fitzgerald LP Chief Executive Officer Howard Lutnick settled a lawsuit over his $50 million bonus tied to Newmark Group Inc. days before he is set to appear in front of the US Senate for a ...
The Senate Commerce Committee said on Wednesday it would hold a Jan. 29 hearing on President Donald Trump's nominee to lead ...
Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback